Thrombolytic therapy in ST-elevation myocardial infarction
Ir Med J. 2024 Mar 21;117(3):929.NO ABSTRACTPMID:38526317 (Source: Ir Med J)
Source: Ir Med J - March 25, 2024 Category: General Medicine Authors: C Murray R Kumar I Pearson Source Type: research
Thrombolytic therapy in ST-elevation myocardial infarction
Ir Med J. 2024 Mar 21;117(3):929.NO ABSTRACTPMID:38526317 (Source: Ir Med J)
Source: Ir Med J - March 25, 2024 Category: General Medicine Authors: C Murray R Kumar I Pearson Source Type: research
Thrombolytic therapy in ST-elevation myocardial infarction
Ir Med J. 2024 Mar 21;117(3):929.NO ABSTRACTPMID:38526317 (Source: Ir Med J)
Source: Ir Med J - March 25, 2024 Category: General Medicine Authors: C Murray R Kumar I Pearson Source Type: research
Interventions to Support the Return to Work for Individuals with Stroke: A Systematic Review and Meta-analysis
ConclusionPhysiological intervention promoted the RTW of individuals with stroke. But, the effect of psychological and work-related interventions in promoting the RTW of individuals with stroke was not significant. We anticipate that these findings may inform the design of future interventions. For future research, we recommend that more high-quality randomized controlled trials be conducted to further promote the RTW of individuals with stroke.Systematic Review Registration: PROSPERO Registration Number, CRD42023443668. (Source: Journal of Occupational Rehabilitation)
Source: Journal of Occupational Rehabilitation - March 21, 2024 Category: Rehabilitation Source Type: research
Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2024 Mar 18. doi: 10.1055/a-2237-7428. Online ahead of print.ABSTRACTAcute pulmonary embolism (PE) remains a significant cause of morbidity and requires prompt diagnosis and management. The prognosis of affected patients depends on the clinical severity. Therefore, risk stratification is imperative for therapeutic decision-making. Patients with high-risk PE need intensive care. These include patients who have successfully survived resuscitation, with obstructive shock or persistent haemodynamic instability. Bedside diagnostics by means of sonographic procedures are of outstanding importance in this high-ri...
Source: Hamostaseologie - March 18, 2024 Category: Hematology Authors: Uwe Janssens Source Type: research
Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2024 Mar 18. doi: 10.1055/a-2237-7428. Online ahead of print.ABSTRACTAcute pulmonary embolism (PE) remains a significant cause of morbidity and requires prompt diagnosis and management. The prognosis of affected patients depends on the clinical severity. Therefore, risk stratification is imperative for therapeutic decision-making. Patients with high-risk PE need intensive care. These include patients who have successfully survived resuscitation, with obstructive shock or persistent haemodynamic instability. Bedside diagnostics by means of sonographic procedures are of outstanding importance in this high-ri...
Source: Hamostaseologie - March 18, 2024 Category: Hematology Authors: Uwe Janssens Source Type: research
Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2024 Mar 18. doi: 10.1055/a-2237-7428. Online ahead of print.ABSTRACTAcute pulmonary embolism (PE) remains a significant cause of morbidity and requires prompt diagnosis and management. The prognosis of affected patients depends on the clinical severity. Therefore, risk stratification is imperative for therapeutic decision-making. Patients with high-risk PE need intensive care. These include patients who have successfully survived resuscitation, with obstructive shock or persistent haemodynamic instability. Bedside diagnostics by means of sonographic procedures are of outstanding importance in this high-ri...
Source: Hamostaseologie - March 18, 2024 Category: Hematology Authors: Uwe Janssens Source Type: research
Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2024 Mar 18. doi: 10.1055/a-2237-7428. Online ahead of print.ABSTRACTAcute pulmonary embolism (PE) remains a significant cause of morbidity and requires prompt diagnosis and management. The prognosis of affected patients depends on the clinical severity. Therefore, risk stratification is imperative for therapeutic decision-making. Patients with high-risk PE need intensive care. These include patients who have successfully survived resuscitation, with obstructive shock or persistent haemodynamic instability. Bedside diagnostics by means of sonographic procedures are of outstanding importance in this high-ri...
Source: Hamostaseologie - March 18, 2024 Category: Hematology Authors: Uwe Janssens Source Type: research
Management of prosthetic valve thrombosis with unfractionated heparin
This study aimed to assess the results of UFH in patients diagnosed with both obstructive and non-obstructive PVT. (Source: International Journal of Cardiology)
Source: International Journal of Cardiology - March 17, 2024 Category: Cardiology Authors: Semih Kalkan, Mustafa Ozan G ürsoy, Ahmet Güner, Macit Kalçık, Emrah Bayam, Sabahattin Gündüz, Mehmet Özkan Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
Evaluation of clinical efficacy of streptokinase by comparison with the thrombolytic agent on animal model
This study aimed to produce streptokinase from Streptococcus pyogenes EBL-48 and compare its efficacy with heparin in an animal model. We evaluated the clot-lysing effectiveness of streptokinase produced from Streptococcus pyogenes EBL-48, emphasizing its low cost and ease of production. Streptokinase was produced using pre-optimized fermentation media and purified through ion exchange and gel-filtration chromatography. In vivo analysis involved inducing clots in a trial animal model using ferric chloride, comparing streptokinase with heparin. Ultrasonography assessed the clot-lysing activity of streptokinase. Streptokinas...
Source: Braz J Biol - February 29, 2024 Category: Biology Authors: S Yousaf M Arshad F A Harraz R Masood M A Zia M Jalalah M Faisal Source Type: research
